期刊文献+

高尿酸血症治疗药物黄嘌呤氧化酶抑制剂的研究进展 被引量:15

Research process of xanthine oxidase inhibitors as hyperuricemia drug
下载PDF
导出
摘要 高尿酸血症是由多种原因引起的代谢性疾病,黄嘌呤氧化酶(XO)是药物治疗高尿酸血症的重要靶点。随着黄嘌呤氧化酶晶体结构的解析、计算机辅助药物设计和高通量筛选等技术的运用,近年涌现了许多具有良好的XO抑制活性的化合物。中药也是我国治疗高尿酸血症的一种主要方式,对天然化合物进行结构修饰也是寻找新化合物的重要方法。该文基于高尿酸血症的产生机制,对具有良好XO抑制活性化合物进行综述。 Hyperuricemia is a metabolic disease resulting from multiple factors,and xanthine oxidase (XO) is an important target for hyperuricemia therapy.Due to the determination of crystal structure of the enzyme and application of CADD and HTS,there emerge a large number of xanthine oxidase inhibitors which have good activity for lowering uric acid in recent years.Using traditional Chinese medicine to treat hyperuricemia is prevalent in China.It is an important method to modificate natural product to find new compounds. In this article,we review the compounds which have excellent inhibitory activity of xanthine oxidase based on the pathological mechanism.
出处 《安徽医药》 CAS 2016年第4期626-630,共5页 Anhui Medical and Pharmaceutical Journal
关键词 高尿酸血症 痛风 尿酸 黄嘌呤氧化酶 hyperuricemia gout uric acid xanthine oxidase
  • 相关文献

参考文献32

  • 1Richette P,Bardin T. Gout [J]. Lancet,2010,375(9711) :318 -328. 被引量:1
  • 2Robinson PC, Simon H. Gout : joints and beyond, epidemiology, clinical features ,treatment and co - morbidities [ J ]. Maturitas ,2014,78 (4) :245 -251. 被引量:1
  • 3邹筱芳,巫冠中.尿酸肾损伤的分子机制研究进展[J].安徽医药,2015,19(1):5-9. 被引量:21
  • 4Bobulescu IA, Moe OW. Renal transport of uric acid: evolving concept.s and uncertainties [J]. Adv Chronic Kidney Dis,2012,19(6) :358 -371. 被引量:1
  • 5Robert T. Update on gout:new therapeutic strategies and options [ J ]. Nat Rev Rheumatol,2010,6(1) :30 -38. 被引量:1
  • 6Parks DA,Granger DN. Xanthine oxidase: biochemistry,distribution and physiology [J]. Acta Physiol Scand Suppl,1986,548( 1 ):87 -99. 被引量:1
  • 7Okamoto K,Kusano T,Nishino T. Chemical Nature and Reaction Mecha- nisms of the Molybdenum Cofactor of Xanthine Oxidoreductase [J]. Curt Pharma Design,2013,19(14) :2606 -2614. 被引量:1
  • 8Okamoto K,Matsumoto K,Hille R,et al. The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction me;chanism and enzyme inhibition [J]. Proc Natl Acad Sci USA,2004,101 (21) :7931 - 7936. 被引量:1
  • 9Yuiehiro Y, Tomohiro M, Kimiyoshi I, et al. Human xanthine oxidase ehanges its substrate specifieity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate [J]. J Bioehem,2007,141 (4) : 513 -524. 被引量:1
  • 10Elion GB. The purine path to chemotherapy [J]. Science 1989,244 (4900) : 509 -529. 被引量:1

二级参考文献35

  • 1张奇,白晓东,付小兵.p38MAPK信号通路研究进展[J].感染.炎症.修复,2005,6(2):121-123. 被引量:28
  • 2Helm t, McFann K, Reed B, et al. Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease [ J . Nephrol Dial Transplant ,2013,28 (2) :380 - 385. 被引量:1
  • 3Takayama S,Kawamoto R,Kusunoki T,et al. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome [ J]. Cardiovasc Diabetol, 2012,11:2. 被引量:1
  • 4Gerseh C,Palii SP, Kim KM, et ai. Inaetivation of nitric oxide by uric acid [ J ]. Nucleosides Nueleotides Nueleic Acids, 2008,27 (8) :967 -978. 被引量:1
  • 5So A,Thorens B. Uric acid transport and disease [ J]. The Journal of clinical investigation,2010,120 (6) : 1791 - 1799. 被引量:1
  • 6Wang Y, Bao X. Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms [ J]. Eur J Med Res ,2013,18:26. 被引量:1
  • 7Kang DH, Ha SK. Uric acid puzzle:Dual role as anti-oxidant and pro-oxidant[ J ]. Electrolyte Blood Press ,2014,12 ( 1 ) : 1 - 6. 被引量:1
  • 8SOnchez-Lozada LG, Lanaspa MA, Crist6bal-Garcla M, et al. Uric acid-induced endothelial dysfunction is associated with mitochon- drial alterations and decreased intracellular ATP concentrations [ J ]. Nephron Experimental Nephrology, 2012,121 ( 3/4 ) : e71 - e78. 被引量:1
  • 9Hong Q, Qi K, Feng Z, et al. Hyperurieemia induces endothelial dysfunction via mitoehondrial Na + Caz + exchanger-mediated mi- tochondrial calcium overload [ J]. Cell Calcium,2012,51 ( 5 ) : 402 -410. 被引量:1
  • 10Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease[J]. Ren Fail,2012,34(4) :510 -520. 被引量:1

共引文献20

同被引文献157

引证文献15

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部